P. Pinto

Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting

D. Perani, S. Cappa, A. Falini, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy

G. Magnani, G. Comi, R. Santangelo, 2014, Neurological Sciences.

Cerebrospinal Fluid Amyloid-β 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer's Disease.

G. Magnani, G. Comi, R. Santangelo, 2017, Journal of Alzheimer's disease : JAD.

Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.

M. Falautano, G. Magnani, G. Comi, 2016, Journal of Alzheimer's disease : JAD.

The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "in Vivo" in the Differential Diagnosis of Alzheimer's Dementia.

D. Perani, L. Leocani, M. Falautano, 2019, Current Alzheimer research.

CSF p-tau/Aβ42 ratio and brain FDG-PET may reliably detect MCI “imminent” converters to AD

D. Perani, M. Filippi, F. Agosta, 2020, European Journal of Nuclear Medicine and Molecular Imaging.

Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.

G. Magnani, G. Comi, R. Santangelo, 2014, Journal of Alzheimer's disease : JAD.

Levodopa Equivalent Dose of Safinamide: A Multicenter, Longitudinal, Case–Control Study

M. T. Pellecchia, A. Tessitore, F. Pistoia, 2023, Movement disorders clinical practice.

123I‐2β‐carbomethoxy‐3β‐(4‐iodophenyl)‐N‐(3‐fluoropropyl) nortropane single photon emission computed tomography and 123I‐metaiodobenzylguanidine myocardial scintigraphy in differentiating dementia with lewy bodies from other dementias: A comparative study

P. Tiraboschi, F. Nobili, L. Antelmi, 2016, Annals of neurology.